Concert Pharmaceuticals, Inc.
CNCEDelisted Mar 6, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001367920
Concert Pharmaceuticals, Inc. was delisted on Mar 6, 2023; its insiders filed their last Form 4 on Mar 6, 2023; 85 institutions reported holding it in 13F filings for Q4 2022, worth $207.2M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Concert Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 79 | 1 | 61 | −17 |
| Shares | 18.3M | 84.4K | 17.5M | −772.4K (−4.2%) |
| Value | $77.2M | $356.0K | $57.1M | −$19.8M (−25.8%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (1)
Institutions that held Concert Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Lake Street Advisors Group, LLC | 35,398 | $116.0K | 0.01% |
Sold out (18)
Institutions that held Concert Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Tibra Equities Europe Ltd | 82,500 | $348.0K |
| Walleye Capital LLC | 69,089 | $292.0K |
| Bank of Montreal | 45,777 | $201.0K |
| AQR Capital Management LLC | 47,245 | $199.0K |
| Jump Financial, LLC | 36,533 | $154.0K |
| Jane Street Group, LLC | 26,404 | $111.0K |
| Deutsche Bank AG | 24,763 | $104.0K |
| AXA S.A. | 22,672 | $96.0K |
| LMR Partners LLP | 15,752 | $66.0K |
| Windsor Creek Advisors, LLC | 13,763 | $58.0K |
| ExodusPoint Capital Management, LP | 12,772 | $54.0K |
| Cubist Systematic Strategies, LLC | 12,452 | $53.0K |
| Winton Group Ltd | 12,648 | $53.0K |
| Citadel Advisors LLC | 10,777 | $45.0K |
| Charles Schwab Investment Management Inc | 10,357 | $44.0K |
| Royal Bank of Canada | 2,253 | $10.0K |
| Nisa Investment Advisors, LLC | 910 | $4.00K |
| New York State Common Retirement Fund | 267 | $1.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Concert Pharmaceuticals, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Kensington Investment Counsel, LLC | 84,368 | $356.0K |